Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05487183 · ClinicalTrials.gov registry record · NA
Test Retest Reliability of OA and OH
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT05487183 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 74 participants.
The verdict
NCT05487183, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The goal of this study is to measure the test retest reliability of offset analgesia (OA) and onset hyperalgesia (OH) across multiple study visits. OA and OH are quantitative sensory tests (QST) thought to measure how the brain modulates pain. This study will use a heat thermode to induce OA and OH in healthy, pain-free volunteers across 3 study visits. Additional QST measures and survey data relevant to pain modulation will be collected. This study lays the foundation required to use OA and OH as tools to measure pain modulation in clinical trials. Following their validation, we anticipate that OA and OH will serve as predictive and therapeutic biomarkers, which will aid both in the development of novel analgesics and in treatment selection leading to the personalization of pain management.
Interventions
- BEHAVIORAL Medoc cutaneous probe
- BEHAVIORAL Quantitative sensory testing
- BEHAVIORAL Computer tasks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-08-05 |
| Est. Completion | 2024-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05487183
The ClinicalTrials.gov registry entry for NCT05487183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Medoc cutaneous probe is the first listed.
NCT05487183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05487183 about?
NCT05487183 is a clinical study titled "Test Retest Reliability of OA and OH". The goal of this study is to measure the test retest reliability of offset analgesia (OA) and onset hyperalgesia (OH) across multiple study visits. OA and OH are quantitative sensory tests (QST) thought to measure how the brain modulates pain. This study will use a heat thermode to induce OA and OH ...
What is the current status of trial NCT05487183?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2022-08-05. Estimated completion is 2024-04-10.
What interventions are being tested in trial NCT05487183?
The interventions under investigation include: Medoc cutaneous probe (BEHAVIORAL), Quantitative sensory testing (BEHAVIORAL), Computer tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT05487183?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.